[go: up one dir, main page]

BR9803982A - Polietilenoiminas de baixo peso molecular, toleráveis biologicamente. - Google Patents

Polietilenoiminas de baixo peso molecular, toleráveis biologicamente.

Info

Publication number
BR9803982A
BR9803982A BR9803982-2A BR9803982A BR9803982A BR 9803982 A BR9803982 A BR 9803982A BR 9803982 A BR9803982 A BR 9803982A BR 9803982 A BR9803982 A BR 9803982A
Authority
BR
Brazil
Prior art keywords
molecular weight
low molecular
biologically tolerable
polyethyleneimines
weight polyethyleneimines
Prior art date
Application number
BR9803982-2A
Other languages
English (en)
Inventor
Thomas Prof Dr Kissel
Dagmar Dr Fischer
Hans-Peter Dr Elsaesser
Thorsten Bieber
Original Assignee
Hoechst Marion Roussel De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel De Gmbh filed Critical Hoechst Marion Roussel De Gmbh
Publication of BR9803982A publication Critical patent/BR9803982A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Lubricants (AREA)
  • Developing Agents For Electrophotography (AREA)

Abstract

Patente de Invenção:<B> "POLIETILENOIMINAS DE BAIXO PESO MOLECULAR, TOLERáVEIS BIOLOGICAMENTE"<D>. A invenção refere-se a polietilenoiminas de baixo peso molecular, vetores para a introdução de ácidos nucléicos em células, que contêm polietilenoiminas de baixo peso molecular, bem como à preparação e aplicação da polietilenoimina de baixo peso molecular e do vetor. A invenção refere-se a um vetor para a introdução de um ácido nucléico em uma célula, contendo uma polietilenoimina de baixo peso molecular (LMW-PE) e um ácido nucléico, sendo que o LMW-PEI apresenta um peso molecular inferior a 50.000 Da.
BR9803982-2A 1997-09-30 1998-09-29 Polietilenoiminas de baixo peso molecular, toleráveis biologicamente. BR9803982A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19743135A DE19743135A1 (de) 1997-09-30 1997-09-30 Biologisch verträgliche niedermolekular Polyethylenimine

Publications (1)

Publication Number Publication Date
BR9803982A true BR9803982A (pt) 2000-03-28

Family

ID=7844109

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9803982-2A BR9803982A (pt) 1997-09-30 1998-09-29 Polietilenoiminas de baixo peso molecular, toleráveis biologicamente.

Country Status (19)

Country Link
US (2) US8003734B2 (pt)
EP (1) EP0905254B1 (pt)
JP (1) JP4399042B2 (pt)
KR (1) KR19990030290A (pt)
AR (1) AR015726A1 (pt)
AT (1) ATE324397T1 (pt)
AU (1) AU758239B2 (pt)
BR (1) BR9803982A (pt)
CA (1) CA2249058A1 (pt)
CY (1) CY1105109T1 (pt)
CZ (1) CZ310598A3 (pt)
DE (2) DE19743135A1 (pt)
DK (1) DK0905254T3 (pt)
ES (1) ES2264180T3 (pt)
HU (1) HUP9802157A3 (pt)
ID (1) ID20973A (pt)
PL (1) PL328910A1 (pt)
PT (1) PT905254E (pt)
TR (1) TR199801933A2 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19956029A1 (de) * 1999-11-22 2001-05-23 Aventis Pharma Gmbh Trägersysteme enthaltend Hüllsubstanzen mit enzymatisch abspaltbaren Seitengruppen
DE19960206A1 (de) * 1999-12-14 2001-07-19 Frank Czubayko Komplexierung von RNS mit Polyethyleniminen zur deren Stabilisierung und zellulären Einschleusung
FR2805271B1 (fr) * 2000-02-18 2002-04-26 Aventis Pharma Sa Procede de preparation de polyalkylenimines fonctionnalises, compositions les contenant et leurs utilisations
IL151289A0 (en) * 2000-02-18 2003-04-10 Aventis Pharma Sa Method for preparing functionalised polyalkylenimines, composition containing same and uses thereof
US6696038B1 (en) * 2000-09-14 2004-02-24 Expression Genetics, Inc. Cationic lipopolymer as biocompatible gene delivery agent
DE10145134A1 (de) * 2000-10-09 2002-05-16 Bayer Ag Komplexe zur Einführung von Nukleinsäuren in Zellen
JP2004510829A (ja) * 2000-10-09 2004-04-08 バイエル　アクチェンゲゼルシャフト 核酸を細胞内に転移させるための複合体
WO2003038103A1 (en) * 2001-10-29 2003-05-08 Atso Raasmaja Method for gene transfection using synergistic combinations of cationic lipids and cationic polymers
US7824910B2 (en) 2001-11-29 2010-11-02 Nippon Shokubai Co., Ltd. Method of transducing a protein into cells
WO2003072637A1 (en) * 2002-02-22 2003-09-04 Insert Therapeutics, Inc. Carbohydrate-modified polymers, compositions and uses related thereto
US20040048260A1 (en) * 2002-09-10 2004-03-11 Fu-Hsiung Chang Transfection of nucleic acid
US20040138154A1 (en) 2003-01-13 2004-07-15 Lei Yu Solid surface for biomolecule delivery and high-throughput assay
WO2004083450A2 (en) * 2003-03-21 2004-09-30 The General Hospital Corporation D/B/A Massachusetts General Hospital Hyperbranched dendron and methods of synthesis and use thereof
JP2007043972A (ja) * 2005-08-10 2007-02-22 Tokyo Institute Of Technology アパタイト粒子及びその作製方法、遺伝子−アパタイト粒子複合体及びその作製方法、並びに遺伝子導入方法及び遺伝子導入用キット
US20080145893A1 (en) * 2006-09-17 2008-06-19 Excellegene Sa Method for producing a recombinant protein at high specific productivity, high batch yield and high volumetric yield by means of transient transfection
CA2694610A1 (en) * 2007-07-31 2009-02-05 Polyplus Transfection Method for manufacturing linear polyethylenimine (pei) for transfection purpose and linear pei obtained with such method
FR2928373B1 (fr) * 2008-03-05 2010-12-31 Centre Nat Rech Scient Polymere derive de la polyethylenimine lineaire pour le transfert de gene.
EP2453911A1 (en) 2009-04-30 2012-05-23 Genetic Immunity Kft Immunogenic nanomedicine composition and preparation and uses thereof
EP2488210A4 (en) 2009-10-12 2014-04-30 Smith Holdings Llc METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION USING IN VITO OR IN VITRO-ADMINISTERED OLIGONUCLEOTIDE MEDICAMENTS
US10722462B2 (en) * 2014-12-10 2020-07-28 Council Of Scientific And Industrial Research Discontinuous reverse micellar composition in cubic FD3M phase for sustained release of therapeutic drugs
JP6873418B2 (ja) * 2016-11-11 2021-05-19 国立大学法人北陸先端科学技術大学院大学 遺伝子導入された細胞の製造方法及びポリエチレンイミンの置換体ポリマー
CA3044891A1 (en) 2016-12-01 2018-06-07 Norbert Gretz Means and methods for visualization of tissue structures
CN112237633B (zh) * 2020-10-22 2023-06-27 林君玉 一种pei/on复合物及其制备方法和用途

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2182306A (en) * 1935-05-10 1939-12-05 Ig Farbenindustrie Ag Polymerization of ethylene imines
NL45673C (pt) * 1935-05-11
DE2530042C3 (de) * 1975-07-04 1982-04-22 Institut neftechimičeskogo sinteza imeni A.V. Topčieva Akademii Nauk SSSR, Moskva Verfahren zur Herstellung von linearem Polyäthylenimin
US4032480A (en) * 1975-07-11 1977-06-28 David Solomonovich Zhuk Method of producing linear polyethylenimine
GB2128625B (en) * 1982-10-07 1986-01-08 Inst Neftechimicheskogo Sintez Method for preparing branched polyethylenimine
US4599400A (en) 1984-12-18 1986-07-08 The Dow Chemical Company Star/comb-branched polyamide
US5714166A (en) 1986-08-18 1998-02-03 The Dow Chemical Company Bioactive and/or targeted dendrimer conjugates
GB8621337D0 (en) * 1986-09-04 1986-10-15 Agricultural Genetics Co Non-radioactive nucleic acid hybridization probes
US5977307A (en) 1989-09-07 1999-11-02 Alkermes, Inc. Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins
US6036955A (en) 1992-03-05 2000-03-14 The Scripps Research Institute Kits and methods for the specific coagulation of vasculature
FR2722506B1 (fr) * 1994-07-13 1996-08-14 Rhone Poulenc Rorer Sa Composition contenant des acides nucleiques, preparation et utilisations
CA2226299A1 (en) 1995-08-11 1997-02-27 Dendritech, Inc. Hyper comb-branched polymer conjugates
CA2229266C (en) * 1995-09-18 2001-10-16 Delta Chemical Corporation Polyaluminum chlorides and polyaluminum chlorosulfates methods and compositions
DE19605279A1 (de) 1996-02-13 1997-08-14 Hoechst Ag Zielzellspezifische Vektoren für die Einschleusung von Genen in Zellen, Arzneimittel enthaltend derartige Vektoren und deren Verwendung
US5962429A (en) * 1996-11-22 1999-10-05 University Of Iowa Complexes of adenovirus with cationic molecules
DE19649645A1 (de) 1996-11-29 1998-06-04 Hoechst Ag Mehrfach funktionelles Ligandensystem zur zielzellspezifischen Übertragung von Nukleotidsequenzen
US5830730A (en) 1997-05-08 1998-11-03 The Regents Of The University Of California Enhanced adenovirus-assisted transfection composition and method

Also Published As

Publication number Publication date
ID20973A (id) 1999-04-01
DE19743135A1 (de) 1999-04-01
AU8714898A (en) 1999-04-22
PT905254E (pt) 2006-08-31
KR19990030290A (ko) 1999-04-26
TR199801933A2 (xx) 1999-04-21
EP0905254A2 (de) 1999-03-31
CA2249058A1 (en) 1999-03-30
HU9802157D0 (en) 1998-12-28
PL328910A1 (en) 1999-04-12
US20030027784A1 (en) 2003-02-06
CY1105109T1 (el) 2009-11-04
ATE324397T1 (de) 2006-05-15
HUP9802157A2 (hu) 1999-06-28
ES2264180T3 (es) 2006-12-16
US8003734B2 (en) 2011-08-23
AU758239B2 (en) 2003-03-20
JP4399042B2 (ja) 2010-01-13
AR015726A1 (es) 2001-05-16
US20110306656A1 (en) 2011-12-15
CZ310598A3 (cs) 1999-04-14
DE59813507D1 (de) 2006-06-01
HUP9802157A3 (en) 2003-02-28
DK0905254T3 (da) 2006-08-21
EP0905254A3 (de) 2002-01-02
EP0905254B1 (de) 2006-04-26
JPH11187874A (ja) 1999-07-13

Similar Documents

Publication Publication Date Title
BR9803982A (pt) Polietilenoiminas de baixo peso molecular, toleráveis biologicamente.
BR9804896A (pt) Dna isolado e purificado, célula hospedeira, vetor, polinucleotídeo quimérico, plasmídeo e processo para aumentar a transcrição de um gene de interesse em uma célula hospedeira
PT873405E (pt) Elementos de sequencia que aumentam a expressao (ease) para sistemas de expressao eucarioticos
BR9815855A (pt) Genes e métodos para controle de nematóides em plantas
BR0007414A (pt) Expressão e exportação de proteìnas antiobesidade como proteìnas de fusão fc
HK1056678A1 (en) Immunostimulatory oligodeoxynucleotides
BR9813968A (pt) Moléculas de ácido nucléico que codificam proteìnas tendo atividade frutosil transferase e processos para produzir inulina de cadeia longa
BR9306856A (pt) Molécula de dna recombinante dna purificado vetor de dna recombinante vetor de plasmida de dna microrganismo transformado bactéria transformada método para dessulfurar um combustível fóssil sonda de ácido nucleico e proteína recombinante
BR0014486A (pt) Composições farmacêuticas contendo polipeptìdeo lìquido estabilizado
AR031912A2 (es) Subtilasa modificada, acido nucleico, vector, celula microbiana y metodo para producirla
BR0207854A (pt) Tecnologia de expressão para proteìnas contendo uma porção de anticorpo de isotipo hìbrido
ATE309378T1 (de) Abgeschwächter salmonellenstamm, gebraucht als vehikel zur oralen immunisierung
DE69528362D1 (de) Oligomere phosphoramidat- und phosphorthioamidatverbindungen
NO20033941L (no) Sammensetning som forbedrer aldersrelaterte fysiologiske mangler som forlenger levetiden
BR9915651A (pt) Processo para a preparação de ácidos alcanossulfÈnicos.
DK2351844T3 (da) Præparater til forøgelse af transport- og antisense-effektivitet af nukleinsyreanalog i celler
ES2183133T3 (es) Composiciones de lipidos.
BR9809910A (pt) Peptìdeos lh-rh análogos, seus usos e composições farmacêuticas contendo-os
BR9713338A (pt) Benzonaftiridinas como terapêuticos brÈnquicos.
BR0114199A (pt) Sequências de nucleotìdeos que medeiam a fertilidade masculina e métodos de uso das mesmas
BR9911898A (pt) Molécula de ácido nucleico codificando pelo menos parte de uma policetìdeo sintase, ventor, célula hospedeira, processos para a produção de um ácido nucleico codificando uma nova policetìdeo sintase, para a produção de um produto de fermentação contendo um policetìdeo e para a produção de um policetìdeo, e, produto de fermentação
DK1175489T3 (da) Oligonukleotider indeholdende en antisense-sekvens stabiliseret af en sekundær struktur og farmaceutiske præparater indeholdende disse oligonukleotider
ATE470713T1 (de) Polypeptidvarianten mit erhoehter heparin- bindungsfaehigkeit
ATE171212T1 (de) Corticotropin freisetzende rezeptoren des faktor 2
BR9813099A (pt) Seleção positiva-negativa na recombinação homóloga

Legal Events

Date Code Title Description
TC Change of name
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1861 DE 05/09/2006.

B15K Others concerning applications: alteration of classification

Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: C12N 15/64; C12N 15/87; A61K 48/00; A61K 47/48; A61P 43/00.

Ipc: A61K 48/00 (2006.01), A61K 47/59 (2017.01), C12N 1

Ipc: A61K 48/00 (2006.01), A61K 47/59 (2017.01), C12N 1